nodes	percent_of_prediction	percent_of_DWPC	metapath
Fidaxomicin—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.134	0.514	CbGbCtD
Fidaxomicin—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.127	0.486	CbGbCtD
Fidaxomicin—Metabolic acidosis—Formoterol—chronic obstructive pulmonary disease	0.0265	0.0359	CcSEcCtD
Fidaxomicin—Metabolic acidosis—Arformoterol—chronic obstructive pulmonary disease	0.0265	0.0359	CcSEcCtD
Fidaxomicin—Metabolic acidosis—Salbutamol—chronic obstructive pulmonary disease	0.025	0.0339	CcSEcCtD
Fidaxomicin—Intestinal obstruction—Tiotropium—chronic obstructive pulmonary disease	0.0191	0.0258	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Roflumilast—chronic obstructive pulmonary disease	0.0109	0.0148	CcSEcCtD
Fidaxomicin—Immune system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00937	0.0127	CcSEcCtD
Fidaxomicin—Malnutrition—Roflumilast—chronic obstructive pulmonary disease	0.00903	0.0122	CcSEcCtD
Fidaxomicin—Dysgeusia—Roflumilast—chronic obstructive pulmonary disease	0.00884	0.012	CcSEcCtD
Fidaxomicin—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.00825	0.0112	CcSEcCtD
Fidaxomicin—Dysphagia—Tiotropium—chronic obstructive pulmonary disease	0.00815	0.011	CcSEcCtD
Fidaxomicin—Hyperglycaemia—Aminophylline—chronic obstructive pulmonary disease	0.00779	0.0105	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.00763	0.0103	CcSEcCtD
Fidaxomicin—Hyperglycaemia—Tiotropium—chronic obstructive pulmonary disease	0.00735	0.00995	CcSEcCtD
Fidaxomicin—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00723	0.00978	CcSEcCtD
Fidaxomicin—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.00716	0.00969	CcSEcCtD
Fidaxomicin—Alanine aminotransferase increased—Montelukast—chronic obstructive pulmonary disease	0.00657	0.0089	CcSEcCtD
Fidaxomicin—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.00649	0.00878	CcSEcCtD
Fidaxomicin—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00641	0.00867	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00636	0.00861	CcSEcCtD
Fidaxomicin—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.0063	0.00853	CcSEcCtD
Fidaxomicin—Abdominal distension—Salbutamol—chronic obstructive pulmonary disease	0.00625	0.00846	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00603	0.00815	CcSEcCtD
Fidaxomicin—Hyperglycaemia—Formoterol—chronic obstructive pulmonary disease	0.00593	0.00803	CcSEcCtD
Fidaxomicin—Hyperglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.00593	0.00803	CcSEcCtD
Fidaxomicin—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00589	0.00797	CcSEcCtD
Fidaxomicin—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00582	0.00788	CcSEcCtD
Fidaxomicin—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.00568	0.00768	CcSEcCtD
Fidaxomicin—Hyperglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.0056	0.00758	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Montelukast—chronic obstructive pulmonary disease	0.00543	0.00735	CcSEcCtD
Fidaxomicin—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00543	0.00735	CcSEcCtD
Fidaxomicin—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.00519	0.00702	CcSEcCtD
Fidaxomicin—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00487	0.00659	CcSEcCtD
Fidaxomicin—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00482	0.00652	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.0048	0.0065	CcSEcCtD
Fidaxomicin—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00475	0.00643	CcSEcCtD
Fidaxomicin—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.00475	0.00643	CcSEcCtD
Fidaxomicin—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00473	0.0064	CcSEcCtD
Fidaxomicin—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00469	0.00634	CcSEcCtD
Fidaxomicin—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.00466	0.0063	CcSEcCtD
Fidaxomicin—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00465	0.00629	CcSEcCtD
Fidaxomicin—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00464	0.00628	CcSEcCtD
Fidaxomicin—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00462	0.00625	CcSEcCtD
Fidaxomicin—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.00458	0.0062	CcSEcCtD
Fidaxomicin—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.00458	0.0062	CcSEcCtD
Fidaxomicin—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00454	0.00615	CcSEcCtD
Fidaxomicin—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.0045	0.00609	CcSEcCtD
Fidaxomicin—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00449	0.00608	CcSEcCtD
Fidaxomicin—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.00449	0.00607	CcSEcCtD
Fidaxomicin—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.00449	0.00607	CcSEcCtD
Fidaxomicin—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00438	0.00592	CcSEcCtD
Fidaxomicin—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.00433	0.00586	CcSEcCtD
Fidaxomicin—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00433	0.00585	CcSEcCtD
Fidaxomicin—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00427	0.00578	CcSEcCtD
Fidaxomicin—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.00426	0.00577	CcSEcCtD
Fidaxomicin—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.00424	0.00573	CcSEcCtD
Fidaxomicin—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.00419	0.00567	CcSEcCtD
Fidaxomicin—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.00419	0.00567	CcSEcCtD
Fidaxomicin—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.0041	0.00555	CcSEcCtD
Fidaxomicin—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00408	0.00552	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00402	0.00544	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.004	0.00541	CcSEcCtD
Fidaxomicin—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00396	0.00536	CcSEcCtD
Fidaxomicin—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.00395	0.00535	CcSEcCtD
Fidaxomicin—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00388	0.00526	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00387	0.00524	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00387	0.00524	CcSEcCtD
Fidaxomicin—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00382	0.00516	CcSEcCtD
Fidaxomicin—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00382	0.00516	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00379	0.00514	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00379	0.00513	CcSEcCtD
Fidaxomicin—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00367	0.00496	CcSEcCtD
Fidaxomicin—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00367	0.00496	CcSEcCtD
Fidaxomicin—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00366	0.00496	CcSEcCtD
Fidaxomicin—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00363	0.00492	CcSEcCtD
Fidaxomicin—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00363	0.00492	CcSEcCtD
Fidaxomicin—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00362	0.0049	CcSEcCtD
Fidaxomicin—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.0036	0.00488	CcSEcCtD
Fidaxomicin—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00359	0.00486	CcSEcCtD
Fidaxomicin—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.00359	0.00485	CcSEcCtD
Fidaxomicin—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00356	0.00481	CcSEcCtD
Fidaxomicin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00348	0.0047	CcSEcCtD
Fidaxomicin—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00346	0.00469	CcSEcCtD
Fidaxomicin—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00343	0.00464	CcSEcCtD
Fidaxomicin—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00341	0.00462	CcSEcCtD
Fidaxomicin—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00333	0.00451	CcSEcCtD
Fidaxomicin—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00333	0.00451	CcSEcCtD
Fidaxomicin—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00329	0.00445	CcSEcCtD
Fidaxomicin—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00329	0.00445	CcSEcCtD
Fidaxomicin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00328	0.00444	CcSEcCtD
Fidaxomicin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00325	0.0044	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00323	0.00437	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00323	0.00437	CcSEcCtD
Fidaxomicin—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00322	0.00436	CcSEcCtD
Fidaxomicin—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.0032	0.00433	CcSEcCtD
Fidaxomicin—Constipation—Formoterol—chronic obstructive pulmonary disease	0.0032	0.00433	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00316	0.00428	CcSEcCtD
Fidaxomicin—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00315	0.00426	CcSEcCtD
Fidaxomicin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00312	0.00423	CcSEcCtD
Fidaxomicin—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00311	0.00421	CcSEcCtD
Fidaxomicin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.0031	0.00419	CcSEcCtD
Fidaxomicin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.0031	0.00419	CcSEcCtD
Fidaxomicin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00308	0.00417	CcSEcCtD
Fidaxomicin—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00307	0.00415	CcSEcCtD
Fidaxomicin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00306	0.00415	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00306	0.00414	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00306	0.00414	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00305	0.00413	CcSEcCtD
Fidaxomicin—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00302	0.00409	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.003	0.00405	CcSEcCtD
Fidaxomicin—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00299	0.00405	CcSEcCtD
Fidaxomicin—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00296	0.004	CcSEcCtD
Fidaxomicin—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00296	0.004	CcSEcCtD
Fidaxomicin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00295	0.00399	CcSEcCtD
Fidaxomicin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00292	0.00395	CcSEcCtD
Fidaxomicin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00292	0.00395	CcSEcCtD
Fidaxomicin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00292	0.00395	CcSEcCtD
Fidaxomicin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.0029	0.00393	CcSEcCtD
Fidaxomicin—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.0029	0.00392	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00289	0.00391	CcSEcCtD
Fidaxomicin—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00279	0.00378	CcSEcCtD
Fidaxomicin—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00276	0.00373	CcSEcCtD
Fidaxomicin—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00276	0.00373	CcSEcCtD
Fidaxomicin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00275	0.00372	CcSEcCtD
Fidaxomicin—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.0027	0.00365	CcSEcCtD
Fidaxomicin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00265	0.00358	CcSEcCtD
Fidaxomicin—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00265	0.00358	CcSEcCtD
Fidaxomicin—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.00264	0.00357	CcSEcCtD
Fidaxomicin—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.00261	0.00353	CcSEcCtD
Fidaxomicin—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.0026	0.00352	CcSEcCtD
Fidaxomicin—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00259	0.00351	CcSEcCtD
Fidaxomicin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.0025	0.00338	CcSEcCtD
Fidaxomicin—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00247	0.00335	CcSEcCtD
Fidaxomicin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00247	0.00335	CcSEcCtD
Fidaxomicin—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00242	0.00328	CcSEcCtD
Fidaxomicin—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.00242	0.00328	CcSEcCtD
Fidaxomicin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00238	0.00322	CcSEcCtD
Fidaxomicin—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00238	0.00322	CcSEcCtD
Fidaxomicin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00236	0.00319	CcSEcCtD
Fidaxomicin—Rash—Formoterol—chronic obstructive pulmonary disease	0.00236	0.00319	CcSEcCtD
Fidaxomicin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00236	0.00319	CcSEcCtD
Fidaxomicin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00236	0.00319	CcSEcCtD
Fidaxomicin—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00234	0.00317	CcSEcCtD
Fidaxomicin—Headache—Formoterol—chronic obstructive pulmonary disease	0.00234	0.00317	CcSEcCtD
Fidaxomicin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00234	0.00316	CcSEcCtD
Fidaxomicin—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.00233	0.00316	CcSEcCtD
Fidaxomicin—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00233	0.00315	CcSEcCtD
Fidaxomicin—Rash—Montelukast—chronic obstructive pulmonary disease	0.00231	0.00313	CcSEcCtD
Fidaxomicin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00231	0.00312	CcSEcCtD
Fidaxomicin—Headache—Montelukast—chronic obstructive pulmonary disease	0.00229	0.00311	CcSEcCtD
Fidaxomicin—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.00227	0.00307	CcSEcCtD
Fidaxomicin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00225	0.00304	CcSEcCtD
Fidaxomicin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00223	0.00301	CcSEcCtD
Fidaxomicin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00222	0.00301	CcSEcCtD
Fidaxomicin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00222	0.00301	CcSEcCtD
Fidaxomicin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00222	0.00301	CcSEcCtD
Fidaxomicin—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00221	0.00299	CcSEcCtD
Fidaxomicin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00218	0.00294	CcSEcCtD
Fidaxomicin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.0021	0.00284	CcSEcCtD
Fidaxomicin—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.00187	0.00253	CcSEcCtD
Fidaxomicin—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.0018	0.00244	CcSEcCtD
Fidaxomicin—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.00167	0.00226	CcSEcCtD
Fidaxomicin—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.00165	0.00223	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.00152	0.00206	CcSEcCtD
Fidaxomicin—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00149	0.00202	CcSEcCtD
Fidaxomicin—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.00144	0.00195	CcSEcCtD
Fidaxomicin—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.00143	0.00193	CcSEcCtD
Fidaxomicin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00134	0.00181	CcSEcCtD
Fidaxomicin—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.0013	0.00175	CcSEcCtD
Fidaxomicin—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.00128	0.00173	CcSEcCtD
Fidaxomicin—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00128	0.00173	CcSEcCtD
Fidaxomicin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00128	0.00173	CcSEcCtD
Fidaxomicin—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00127	0.00172	CcSEcCtD
Fidaxomicin—Constipation—Prednisone—chronic obstructive pulmonary disease	0.00126	0.0017	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.0012	0.00163	CcSEcCtD
Fidaxomicin—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.0012	0.00163	CcSEcCtD
Fidaxomicin—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.00116	0.00157	CcSEcCtD
Fidaxomicin—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.00108	0.00147	CcSEcCtD
Fidaxomicin—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.00104	0.00141	CcSEcCtD
Fidaxomicin—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000973	0.00132	CcSEcCtD
Fidaxomicin—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000936	0.00127	CcSEcCtD
Fidaxomicin—Rash—Prednisone—chronic obstructive pulmonary disease	0.000928	0.00126	CcSEcCtD
Fidaxomicin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000927	0.00125	CcSEcCtD
Fidaxomicin—Headache—Prednisone—chronic obstructive pulmonary disease	0.000922	0.00125	CcSEcCtD
Fidaxomicin—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000874	0.00118	CcSEcCtD
